Our Partners

Avanos Medical

Avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter.
We believe a difference in our products, combined with a difference in how we work, communicate and partner, can change the entire world.

We are committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.


KiteLock™ is transforming central venous access care by providing a powerful solution to maintain patency and by reducing the risk of bacterial colonization and biofilm formation within central venous access devices (CVADs).
Simply eliminating the risk of clots is no longer sufficient. Within seven days, CVADs can become colonized with microorganisms embedded in biofilm resulting in a potential source of life threatening infections.5


The Company’s first product is the SecurAcath Subcutaneous Catheter Securement System. This simple, yet revolutionary device, makes it possible to hold virtually any catheter securely in place without sutures or adhesives. SecurAcath is now gaining widespread acceptance in the US, Europe and Canada. With the success of SecurAcath serving as a solid foundation for future growth, the company continues to collaborate with highly regarded physicians in the development of unique solutions for large, growing patient populations.

Balt Medical

For 40 years, Balt has been a global leader in the innovation of novel products for the interventional access and treatment of neurovascular diseases. With one of the most comprehensive product portfolios available, Balt products are used around the world to access and treat multiple disease states including arterial venous malformations, aneurysms, and ischemic stroke.


GEM is an Italian manufacturer and distributor of medical devices. In 1995 GEM commercializes the Glubran glue, to be used in surgical procedures. Soon after, GEM manufactured the second generation of the product Glubran 2 with new formula that allows its use even in endovascular procedures. In 1998 both products obtained the CE certification for internal use. In 2007 Glubran Tiss, surgical glue for skin applications, entered the market. At present Glubran 2, Glubran Tiss and their application devices are sold in over 40 countries worldwide.


At Olympus Medical Systems, we focus on improving patient care quality every day. We do this through developing and designing world-leading, clinically-advanced, precision technologies and services. Our products enable healthcare professionals, from a broad range of specialties, to ‘peer’ inside the body, using endoscopic procedures. This allows them to see more and do more. By focusing on early detection and minimally invasive treatment of a broad range of diseases, our mutual mission is to improve patient outcomes, minimize discomfort, and accelerate the recovery process. Our innovative technologies and services can also optimize workflow and maximize operational efficiency.


W.L. GORE is an American Multinational Company that make tissue reinforcement products for Hernia Repair and Gastric BI-Pass procedures. W.L. GORE is a technology-driven global company built on entrepreneurial innovation, integrity and teamwork. For more than 40 years, W.L. GORE have produced reliable, durable and effective surgical products that have and continue to make a difference in the lives of others.


Founded in 2013, VESALIO™ is a privately held medical device company focused on advancing technology needed to improve outcomes in stroke treatment.

The Company’s proprietary NeVa™ platform is designed to achieve superior, safe and repeatable clinical outcomes by providing physicians improved first pass success in effectively removing the entire spectrum of clot from neurovascular anatomy.


Since 2003, Opsens has established itself as a pioneer of innovative fiber optic sensing technology  committed  to quality and excellence. We deliver cost-effective solutions to a variety of sectors, primarily medical, energy and industrial.
Our fundamental objective is to develop and manufacture products as well as tailor a wide range of services for individual industry requirements


Vasorum is developing medical devices for the interventional cardiology and radiology markets. Its first product is the Celt ACD®, used to close arterial puncture holes following catheter-based vascular procedures.


iVascular is a fast-growing company founded in 2010 in Barcelona (Spain) with the aim of developing advanced medical devices and therapies for the treatment of disorders of the vascular system. The team that started iVascular owns more than 20 years of experience in the field of vascular devices, being responsible for achieving one of the first CE marks for a drug-eluting stent more than 12 years ago.

iVascular was born to become a reference in the vascular field by empowering the value of technology. Our staff provides extensive knowledge in biopolymers, coatings and drug delivery. Together they bring recognized experience in the development of medical devices and implants.

Quality system in iVascular has the main purpose of achieving excellence in all processes. Thus, we aim to supply products and services compliant with the optimum quality standards to obtain the satisfaction of our customers.


Cerus Endovascular is a privately owned medical device company based in Fremont, California and Oxford, United Kingdom. We design, develop, manufacture and supply Neurovascular products used by Interventional Neuroradiologists for the treatment of haemorrhagic strokes. 

We manufacture our portfolio of embolization devices at our 12,000sq feet California facility, where we also operate a 1,500sq feet class 10,000 clean room which provides us with the operational capacity to meet the demands of our clinical partners across our entire range of products.